BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
14.95
-0.46 (-2.99%)
Jan 7, 2026, 2:07 PM EST - Market open
BioAge Labs Analyst Ratings
Total Analysts
3
Consensus Rating
Buy
Price Target
$13.50
Upside
-9.70%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Sell → Hold Upgrades $5 → $12 | Sell → Hold | Upgrades | $5 → $12 | -19.73% | Dec 8, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $10 → $15 | Strong Buy | Maintains | $10 → $15 | +0.33% | Oct 29, 2025 |
| Citigroup | Citigroup | Hold → Strong Buy Upgrades $5 → $10 | Hold → Strong Buy | Upgrades | $5 → $10 | -33.11% | Oct 22, 2025 |
| Citigroup | Citigroup | Hold Maintains $7 → $5 | Hold | Maintains | $7 → $5 | -66.56% | Mar 24, 2025 |
| Morgan Stanley | Morgan Stanley | Sell Initiates $5 | Sell | Initiates | $5 | -66.56% | Mar 7, 2025 |
| William Blair | William Blair | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Feb 28, 2025 |
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $45 → $7 | Strong Buy → Hold | Downgrades | $45 → $7 | -53.18% | Dec 9, 2024 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $42 → $7 | Strong Buy → Hold | Downgrades | $42 → $7 | -53.18% | Dec 9, 2024 |
| Citigroup | Citigroup | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +201.00% | Oct 21, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $40 | Buy | Initiates | $40 | +167.56% | Oct 21, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $42 | Strong Buy | Initiates | $42 | +180.94% | Oct 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $12 → $1.75 | Strong Buy | Maintains | $12 → $1.75 | -88.29% | Mar 29, 2018 |
| Cowen & Co. | Cowen & Co. | Hold Initiates $2.5 | Hold | Initiates | $2.5 | -83.28% | Apr 12, 2017 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +20.40% | Jan 5, 2016 |